Incidence of and Mortality Due to Cervical Cancer in Kazakhstan

Abstract

Author(s): Nakhanova Zh. K*, K. Toleutaiuly, T. T. Sadykova, M. S. Sadykov, U. K. Zhumashev, Zh. Kalieva and B. K. Kaiken

Despite some stabilization, an examination of the current state of affairs during the last five years reveals that cervical cancer morbidity and mortality in Kazakhstan continue to be a serious issue. The long-term planning of oncological care for patients with cervical cancer will take into consideration the characteristics of cervical cancer morbidity and mortality that have been identified within the Republic of Kazakhstan. In the Republic of Kazakhstan (RK), from 2018 to 2022, an epidemiological analysis of the incidence and mortality rates from Cervical Cancer (??) was carried out. In 2022, for the first time in the Republic of Kazakhstan, 1934 women diagnosed with cervical cancer were registered for dispensary registration and it ranks ninth among all malignant neoplasms, 602 women died. Over the years, the indicators of primary morbidity per 100,000 female population of the RSM are almost at the same level of 19.3% of LLC and 19.4% of LLC and a slight decrease in mortality from 6.4% of LLC to 6.0% of LLC. Regions with a high incidence of morbidity have been identified (Pavlodar, Atyrau, West Kazakhstan and North Kazakhstan). An increase in the specific gravity of stages I-II was noted. The ratio of mortality to morbidity according to standardized indicators decreased from 33.1% to 30.9% during this period, which indicates an improvement in the parameters of providing oncological care to the population of the Republic of Kazakhstan. The identified features of morbidity and mortality from cervical cancer in the territory of the Republic of Kazakhstan will be taken into account in the long-term planning of oncological care for patients with cervical cancer

Share this article